By the end of this module
Recognise the broad clinical footprint of endometriosis, including extra-pelvic and GI-adjacent presentations.
InsideHer Learning · Course 01
Professional learning for dietitians, clinicians, and allied health teams.
Course Overview
This course turns the attached source pack into a practical, easy-to-navigate learning experience. It covers diagnosis, red flags, management pathways, GI symptom overlap, low FODMAP evidence, and dietetic assessment considerations.
Module 1
What endometriosis is, where it can occur, and why disease stage does not map neatly to symptom burden.
Recognise the broad clinical footprint of endometriosis, including extra-pelvic and GI-adjacent presentations.
Classification systems describe disease; they do not reliably predict pain, fatigue, or quality-of-life impact.
Keep language clinically grounded, avoid minimising symptoms, and avoid overexplaining the condition through a single mechanism.
Think in patterns: cycle-linked pain, bowel symptoms, fatigue, fertility concerns, and function loss often travel together.
Endometriosis is a common inflammatory gynaecological condition in which tissue similar to endometrium grows outside the uterus. It commonly affects the peritoneum, ovaries, and fallopian tubes, but it can also affect the bladder, bowel, lungs, and more distant sites.
A practical takeaway for clinicians is that pelvic symptoms are common, but pelvic location alone should not narrow thinking too early when cyclical extra-pelvic symptoms are present.
The attached course material notes that prevalence estimates vary internationally, while Australian estimates suggest endometriosis may affect around 1 in 7 females up to ages 44 to 49 when clinically suspected and surgically confirmed cases are combined.
The burden extends well beyond pain. Work, study, social life, relationships, fertility, mental health, and finances are all commonly affected.
Clinical Insight
The source material is explicit that commonly used classification systems correlate poorly with symptoms, quality of life, and outcomes. More disease on paper does not reliably mean more pain in the room.
Common systems include rASRM, Endofound, ENZIAN, and the Endometriosis Fertility Index.
The course source identifies rASRM as the most commonly used staging system in Australia.
Untreated disease is not inevitably progressive. Some cases progress, some remain stable, and some regress.
Pain can become amplified over time, which helps explain persistent symptoms despite treatment.
Module 2
How to recognise red flags, understand diagnostic delay, and interpret investigations without overcalling normal results.
Key Point
The source material emphasises that clinical examination has low diagnostic accuracy, and even high-quality ultrasound may miss superficial peritoneal disease.
The attached material highlights long diagnostic delays, with Australian averages around 8 years. Barriers include symptom normalisation, lack of awareness, limited access to specialist imaging or surgery, stigma, cost, and misdiagnosis as IBS or other chronic pain conditions.
Transvaginal ultrasound is the preferred first-line investigation when appropriate and available.
MRI may help when ultrasound is inconclusive or deep disease is suspected, but it cannot exclude endometriosis.
No biomarker, including CA-125, is accurate enough to diagnose endometriosis on its own.
Still relevant, especially when suspicion remains high despite negative imaging, but not required for every initial clinical diagnosis.
Start with symptoms, timing, impact on function, and whether the pattern is cyclical, progressive, or infertility-linked.
Use examination and ultrasound thoughtfully, recognising both their value and their limitations.
If imaging is negative but clinical suspicion remains high, further specialist review is still appropriate.
Guideline-based treatment can begin in suspected cases, especially when symptoms are significant and pregnancy is not being pursued.
Clinical Scenario
If a patient presents for bloating or bowel symptoms but also reports worsening period pain, pain opening bowels during menstruation, or difficulty conceiving, treat that as a referral trigger back to a GP or gynaecologist rather than a signal to stay only inside nutrition management.
Module 3
Medical, surgical, physiotherapy, psychological, and self-management options, with emphasis on multidisciplinary care.
Paracetamol and NSAIDs may be trialled, but evidence is limited. Opioids are not a good long-term strategy because of dependence risk, constipation, hyperalgesia, and limited benefit in chronic pelvic pain.
First-line hormonal options include combined hormonal contraceptives and progestogens. They suppress ovulation and menstruation and are not appropriate for people actively trying to conceive.
Laparoscopic surgery can diagnose disease, remove lesions, and address anatomical distortion. It can improve quality of life, but it is not curative and recurrence is common.
Pelvic floor dysfunction, pacing, CBT, ACT, and mindfulness may all have a role, particularly when pain is persistent or function is significantly affected.
The source pack repeatedly points to fragmentation of care as a problem. Patients often want support from doctors, physiotherapists, psychologists, dietitians, and other practitioners, but access is inconsistent and expensive.
Dissatisfaction is driven by delayed diagnosis, persistent pain, side effects, cost, poor access, symptom recurrence, and a narrow treatment focus that may overlook fatigue, psychological distress, or GI symptoms.
Use short trials and regular review. Limited efficacy data should not be mistaken for long-term benefit.
Hormonal suppression is often useful, but it is not appropriate when the patient is actively trying to conceive.
Track work, exercise, sleep, mood, intimacy, and daily participation, not just pain intensity.
Even after surgery, recurrence and repeat procedures are common, so longitudinal care planning matters.
Practice Lens
Patients may be equally burdened by fatigue, bloating, bowel symptoms, fertility concerns, identity disruption, and the feeling of not being believed.
Module 4
How to talk about dietary approaches carefully, and where the low FODMAP evidence is strongest.
The source material describes widespread use of anti-inflammatory eating patterns, gluten restriction, dairy restriction, reduced red meat intake, low nickel diets, and low FODMAP strategies. Most approaches are popular before they are well proven.
That means the dietitian's role is partly therapeutic and partly protective: helping patients avoid unnecessary restriction while still taking symptoms seriously.
InsideHer Guidance
The course source is clear that many diets lack strong efficacy evidence and can increase nutritional risk, food anxiety, cost, and social burden. The objective is symptom relief with the least unnecessary restriction.
EndoFOD Snapshot
In the randomised crossover study referenced in the course material, 60% of participants responded to the low FODMAP diet, with improvements in GI symptoms, abdominal pain, bloating, stool form, and quality of life over 28 days.
The evidence is stronger for GI symptom management than for endometriosis-specific pain. It is not yet proof that low FODMAP changes dysmenorrhoea, dyspareunia, or disease progression.
Module 5
Understanding why bowel symptoms are common in endometriosis and why IBS overlap matters.
The source pack reports GI symptoms may affect 75% to 98% of people with endometriosis.
Cycle timing matters. Symptoms can intensify around menses and overlap closely with IBS patterns.
GI symptoms frequently occur without direct bowel infiltration of disease.
Inflammation, visceral hypersensitivity, microbiota shifts, opioid use, and gut-brain interactions may all contribute.
Overlap Matters
The source pack describes substantial overlap between endometriosis and IBS, including a pooled IBS prevalence of 23.4% among individuals with endometriosis and high rates of endometriosis later confirmed in women previously labelled with IBS.
The attached material explicitly links psychological distress and GI symptom burden. This matters clinically because stress management, pain coping, and GI symptom work often need to sit alongside dietary strategies.
Shared symptom patterns can delay diagnosis, complicate treatment decisions, and tempt over-restriction. Thoughtful history taking helps separate cyclical symptom flares, functional gut features, and medical red flags requiring referral.
Module 6
What to gather in an initial consult, when to refer onward, and how to keep management proportionate.
Document whether diagnosis is based on symptoms, imaging, laparoscopy, or remains suspected but unconfirmed.
Note type, severity, duration, pattern, relation to meals, and relation to the menstrual cycle.
Ask about surgeries, hormone treatments, analgesics, neuromodulators, supplements, and comorbidities.
Screen for restrictive eating, weight change, food fear, low energy intake, low iron, and unintended nutritional compromise.
Include endometriosis, IBS, inflammatory bowel disease, coeliac disease, reflux, and colon cancer where relevant.
Unexplained weight loss, possible coeliac disease, inflammatory features, or other alarm symptoms should prompt medical review before dietary restriction.
Clarify diagnosis, disease location if known, prior surgery, and current medical management.
Characterise GI symptoms carefully using stool pattern, timing, severity, duration, and quality-of-life impact.
Assess menstrual cycle characteristics, iron risk, family history, medications, supplements, and current restrictions.
Decide whether the next best step is diet therapy, further medical investigation, or both in parallel.
Referral Rule
The source material recommends referral back to a GP or gastroenterologist before commencing dietary changes when important alarm features are present.
Check
Use these quick checks to reinforce the core clinical decisions from the source material.
Transvaginal ultrasound, performed by an experienced sonographer where possible.
No. Superficial disease can be missed, and persistent symptoms still matter.
A low FODMAP diet for selected patients with poorly controlled GI symptoms.
No. Restriction should be proportionate, evidence-aware, and followed by liberalisation where possible.
When bowel symptoms are cyclical, linked to periods, combined with dyspareunia, heavy bleeding, or infertility, or have delayed appropriate diagnosis.
Refer for medical review and investigation before pushing ahead with restrictive dietary changes.